[ACRX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 24.04%
YoY- -2.10%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 738 475 613 740 6,435 1,730 226 21.78%
PBT -8,918 -14,423 -12,558 -10,588 -9,682 -10,558 -13,818 -7.03%
Tax 698 885 355 -703 68 -12 -1,218 -
NP -8,918 -14,423 -12,558 -9,885 -9,682 -10,546 -13,818 -7.03%
Tax Rate - - - - - - - -
Total Cost 9,656 14,898 13,171 10,625 16,117 12,276 14,044 -6.04%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -1,208.40 -3,036.42 -2,048.61 -1,335.81 -150.46 -609.60 -6,114.16 -23.65%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -1.93 -3.63 -3.56 -3.88 -4.27 -4.66 -6.30 -17.88%
EPS Diluted -1.93 -3.63 -3.56 -3.88 -4.27 -4.66 -6.22 -17.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.